Misonidazole in patients receiving radical radiotherapy: Pharmac-okinetic effects of phenytoin tumor response and neurotoxicity
- 30 April 1982
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (3-4) , 361-364
- https://doi.org/10.1016/0360-3016(82)90640-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patientsBritish Journal of Cancer, 1981
- Pilot study of radiotherapy with misonidazole in head and neck cancerClinical Radiology, 1980
- The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasoneThe British Journal of Radiology, 1980
- Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicityBritish Journal of Cancer, 1980
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCERThe Lancet, 1977
- RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCERThe Lancet, 1977
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977